WEDI names 2013 officers

Luke Gale | | Health Exec | Informatics

The Workgroup for Electronic Data Exchange announced the 2013 class of officers for its board of directors.

Jim Daley, director of risk & compliance for BlueCross BlueShield of South Carolina, will serve as the chair; Jean Narcisi, director of dental information for the American Dental Association, will serve as chair-elect; Gail Kocher, director of the industry standards and e-health team for the Blue Cross and Blue Shield Association, will serve as vice chair of administration and operations; Laurie Darst, regulatory advisor for the department of finance at Mayo Clinic, will serve as vice chair of programs and services; and Rob Tennant, senior policy advisor with the government affairs department for the Medical Group Management Association, will serve as vice chair of marketing and communications. 

Luke Gale

Related Content

Alabama security breach exposes personal information of cardiologists, heart patients
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
Cloud image storage for radiology is a growing trend in healthcare
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.